Back
Cardiol Therapeutics Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
50
CRDL
Cardiol Therapeutics
Last Price:
1.62
Seasonality Move:
35.88%
Buy
79
AUPH
Aurinia Pharmaceuticals
Last Price:
8.88
Seasonality Move:
24.51%
Sell
50
Cardiol Therapeutics (CRDL)
is a Sell
Is Cardiol Therapeutics a Buy, Sell or Hold?
- The current Cardiol Therapeutics [CRDL] share price is $1.62. The Score for CRDL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CRDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRDL Stock Price Chart
What is Cardiol Therapeutics's stock price today?
-
The Cardiol Therapeutics share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDL is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
CRDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 34.48 | Sell |
| Chaikin Money Flow: | 112900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.72 - 1.96) | Sell |
| Bollinger Bands (100): | (1.83 - 2.17) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 72.92 | Buy |
| Chaikin Money Flow: | 122744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.17 - 8.37) | Buy |
| Bollinger Bands (100): | (5.81 - 7.63) | Buy |
CRDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.83 | Sell |
| 50-day SMA: | 1.94 | Sell |
| 200-day SMA: | 1.96 | Sell |
| 8-day EMA: | 1.7 | Sell |
| 20-day EMA: | 1.8 | Sell |
| 50-day EMA: | 1.9 | Sell |
| 200-day EMA: | 1.84 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.34 | Buy |
| 20-day SMA: | 7.95 | Buy |
| 50-day SMA: | 7.43 | Buy |
| 200-day SMA: | 6.09 | Buy |
| 8-day EMA: | 8.41 | Buy |
| 20-day EMA: | 8.03 | Buy |
| 50-day EMA: | 7.49 | Buy |
| 200-day EMA: | 6.84 | Buy |
Cardiol Therapeutics Earnings Growth & CRDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.02 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Cardiol Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||